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Summary
 
Major histocompatibility complex (MHC) class II–positive cell lines which lack HLA-DM ex-
pression accumulate class II molecules associated with residual invariant (I) chain fragments
(class II–associated invariant chain peptides [CLIP]). In vitro, HLA-DM catalyzes CLIP dissoci-
ation from class II–CLIP complexes, promoting binding of antigenic peptides. Here the physi-
cal interaction of HLA-DM with HLA-DR molecules was investigated. HLA-DM complexes
with class II molecules were detectable transiently in cells, peaking at the time when the class II
molecules entered the MHC class II compartment. HLA-DR 
 
ab
 
 dimers newly released from I
chain, and those associated with I chain fragments, were found to associate with HLA-DM in
vivo. Mature, peptide-loaded DR molecules also associated at a low level. These same species,
but not DR-I chain complexes, were also shown to bind to purified HLA-DM molecules in
vitro. HLA-DM interaction was quantitatively superior with DR molecules isolated in associa-
tion with CLIP. DM-DR complexes generated by incubating HLA-DM with purified DR
 
ab
 
CLIP contained virtually no associated CLIP, suggesting that this superior interaction re-
flects a prolonged HLA-DM association with empty class II dimers after CLIP dissociation. In-
cubation of peptide-free 
 
ab
 
 dimers in the presence of HLA-DM was found to prolong their
ability to bind subsequently added antigenic peptides. Stabilization of empty class II molecules
may be an important property of HLA-DM in facilitating antigen processing.
 
T
 
he recognition of antigen by CD4
 
1
 
 T helper cells re-
quires the presentation of short peptides displayed in
the binding groove of MHC class II molecules (1, 2).
MHC class II molecules are cell surface expressed het-
erodimeric (
 
ab
 
) glycoproteins. Newly synthesized class II
 
a
 
 and 
 
b
 
 chains assemble in the ER with a third transmem-
brane glycoprotein, the invariant (I) chain (3, 4). With the
aid of the molecular chaperone calnexin, three 
 
ab
 
 dimers
bind sequentially to a trimer of the I chain in the ER (5, 6).
The nonameric complex moves through the Golgi appara-
tus and is sorted by signals in the cytoplasmic domain of the
I chain (7) and the class II 
 
b
 
 chain (8) to endosomal com-
partments with late endosomal (class II–containing vesicles,
CIIV; 9) or lysosome-like characteristics (MHC class II com-
partment [MIIC]
 
1
 
; 10–13) where the I chain is proteolyti-
cally cleaved by aspartic and cysteine proteases (14–17). The
released 
 
ab
 
 dimers are loaded with peptides derived from
internalized pathogen-derived or endogenous proteins present
in the endocytic system and transported to the cell surface.
The expression of HLA-DM, encoded by MHC-linked
genes (18, 19), is required for class II–restricted processing
and presentation of most protein antigens but not for the
presentation of exogenously added antigenic peptides (re-
viewed in reference 20). Class II molecules in DM-nega-
tive B-lymphoblastoid cell lines (B-LCL) are expressed on
the cell surface at wild-type levels but are associated with a
set of peptides derived from residues 81-104 of the I chain
(class II–associated invariant chain peptides, or CLIP) in-
stead of antigenic peptides (21, 22). Similar complexes ac-
cumulate in class II–positive cell lineages in mice in which
the 
 
Ma
 
 (DMA) gene is disrupted (23–25). The ability to
isolate 
 
ab
 
CLIP complexes from wild-type APCs (2), their
transient appearance during pulse–chase analysis of class II
transport (26–27), and the proteolytic generation of 
 
ab
 
-
CLIP complexes from 
 
ab
 
I in vitro (27), all indicate that
 
ab
 
CLIP complexes are an intermediate in the class II pro-
cessing pathway and that CLIP probably represents the end
product of I chain proteolysis. Recent x-ray crystallo-
graphic analysis of HLA-DR3-CLIP complexes has dem-
onstrated that CLIP binds in the antigen binding groove of
the class II molecules (28) indicating that CLIP must first be
removed before endocytically generated peptides can bind.
 
1
 
Abbreviations used in this paper:
 
 B-LCL, B-lymphoblastoid; CIIV, class II–
containing vesicles; CLIP, class II–associated invariant chain peptides;
DOC, deoxycholate; MIIC, MHC class II compartment.
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Recently, we and others have shown that CLIP removal
and peptide loading are directly catalyzed by DM in vitro
(29–31), suggesting that DM also removes CLIP from 
 
ab
 
-
CLIP complexes in vivo. For DM to catalyze the release of
CLIP, it seemed likely that a DM–class II interaction must
occur and, indeed, Sanderson et al. (32) have shown by co-
precipitation that DM and DR associate under steady state
conditions in vivo. The association is favored by low pH in
the nonionic detergent digitonin, and occurs in dense com-
partments, probably in MIICs. In this study, using bio-
synthetic labeling and coprecipitation of DR with DM, we
show that in vivo the DM-DR association is transient, and
that DM associates with peptide loaded 
 
ab
 
 dimers, extend-
ing the initial observations reported by Sanderson et al.
(32). Additionally, we examine the in vitro interaction of
affinity-purified DM with DR molecules associated with I
chain, fragments of I chain, CLIP, or the normal comple-
ment of peptides expressed in wild-type cells. The results
indicate a degree of specificity for 
 
ab
 
CLIP in the interac-
tion, and suggest that one function of HLA-DM is to pro-
long the survival of empty class II molecules in the MIIC, a
chaperone-like function which is likely to be important in
antigen processing.
 
Materials and Methods
 
Cell Lines.
 
The EBV transformed B-lymphoblastoid cell line
(B-LCL) Pala (HLA-DR3.Dw17) and the T 
 
3
 
 B hybrid cell line
.174 
 
3
 
 CEM.T2 (33) transfected with HLA-DR3 (T2.DR3; 34)
were maintained in Iscove’s DMEM (GIBCO BRL, Gaithers-
burg, MD) with 5% calf serum (GIBCO BRL) in the presence of
5% CO
 
2
 
 at 37
 
8
 
C. The derivation of the mutant B-LCL 10.24.6
(HLA-DR3, -DRw52a, -DQ2, -DP4.1) and the progenitor
BLCL 8.1.6 have been described (35). These cells were main-
tained in RPMI (GIBCO BRL) supplemented with 1% gluta-
mine (GIBCO BRL) and 10% calf serum.
 
Antibodies and Peptide.
 
The hybridoma cell lines L243 (anti-
HLA-DR 
 
ab
 
; 36), DA6.147 (anti-HLA-DR 
 
a
 
 chain; 37),
GAP.A3 (anti-HLA-A3; 38), W6/32 (anti-HLA-class I; 39),
HB10A (anti-HLA-DR 
 
b
 
 chain; 40), PIN.1 (anti-I chain NH
 
2
 
-
terminal; 41), and CerCLIP.1 (anti-CLIP24; 42), have been pre-
viously described. Rabbit anti-DM serum was a generous gift of
Dr. Hans Zweerink (Merck Research Laboratories, Rahway, NJ)
and was generated against recombinant, soluble DM, (31). Rabbit
anti-C23V serum, specific for an influenza hemagglutinin peptide,
was generated in our laboratory and has been described (42).
The DR3-restricted MOMP peptide (QASLALSYRLNM-
FTP; 21) is derived from residues 251-265 of the major outer
membrane protein of 
 
Chlamydia trachomatis
 
 and was synthesized
by the Keck Foundation Biotechnology Resource Laboratory
(Yale University). The peptide was purified by RP-HPLC and
laser desorption mass spectrometry indicated that it was a single
species.
 
Metabolic Labeling.
 
Cells for pulse labeling were washed once
with methionine and cysteine-free DMEM supplemented with
3% dialyzed FBS, 15 mM Hepes, 2 mM glutamine, and 1 mM
sodium pyruvate (labeling medium; all from GIBCO BRL) and
preincubated at 3 
 
3
 
 10
 
6
 
 cells/ml in labeling medium for 60 min
at 37
 
8
 
C. Cells were pelleted and resuspended at 1 
 
3
 
 10
 
7
 
 cells/ml
in fresh labeling medium plus 1 mCi/ml of 
 
l
 
-[
 
35
 
S]methionine in
vitro cell labeling mix (Amersham Corp., Arlington Heights, IL).
After incubation at 37
 
8
 
C for 15 min to 6 h, the pulsed cells were
pelleted, resuspended at 1 
 
3
 
 10
 
6
 
 cells/ml with IDMEM/5% calf
serum/5% FBS containing a 15-fold excess of cold methionine
and cysteine, and then chased for up to 18 h at 37
 
8
 
C. At each
chase point, the cells were diluted into ice-cold serum-free ID-
MEM, pelleted by centrifugation, and either lysed immediately
for immunoprecipitation and affinity purification or stored at
 
2
 
20
 
8
 
C until ready for use.
 
Immunoprecipitations and Endo H Digestion.
 
Radiolabeled cell pel-
lets were extracted for 30 min on ice in 20 mM Tris, 130 mM
NaCl (pH 7.4) (TBS), containing 1% CHAPS (Pierce, Rockford,
IL), or 1% CHAPS plus 1% Triton X-100 (Sigma Chem. Co., St.
Louis, MO), 0.5 mM PMSF, 0.1 mM TLCK, and 5 mM iodoac-
etamide (Sigma) at 5 
 
3
 
 10
 
5
 
–2 
 
3
 
 10
 
6
 
 cells/ml. After the removal
of nuclear material by centrifugation, lysates were precleared with
2 
 
m
 
l normal rabbit serum and 75 
 
m
 
l Zysorbin (Zymed Laborato-
ries, South San Francisco, CA) per ml of cell lysate for 1 h at 4
 
8
 
C
before incubation with specific antibody (2–3 
 
m
 
l ascites or rabbit an-
tiserum, 100 
 
m
 
l tissue culture supernatant) and protein A–Sepharose
(Sigma) or protein G–Sepharose (Pharmacia, Piscataway, NJ). For
anti class II or I chain immunoprecipitations 5 
 
3
 
 10
 
5
 
 cell equiva-
lents were used. For anti DM immunoprecipitation 2 
 
3
 
 10
 
6
 
 cell
equivalents were used. Sepharose pellets were washed three times
with TBS plus 1% CHAPS or 10 mM Tris, pH 8.0, 300 mM
NaCl, 0.1% SDS, 0.05% Triton X-100, or TBS plus 0.1% Tri-
ton-100, and stored at 
 
2
 
20
 
8
 
C. For reprecipitation experiments, 1
ml of TBS containing 0.5% deoxycholate (DOC; Sigma) was
added to the DM precipitates and they were incubated for 3 h at
4
 
8
 
C. After centrifugation, the released DR was immunoprecipi-
tated from the DOC supernatants as described above. For Endo H
digestion, beads were boiled for 5 min in 20 
 
m
 
l of 0.06 M NaPO
 
4
 
,
0.3% SDS, 0.06% NaN
 
3
 
, diluted with 40 
 
m
 
l H
 
2
 
O, and the super-
natants were divided into two aliquots. To one aliquot, 2 mU re-
combinant Endo H (Boehringer Mannheim, Indianapolis, Indiana)
was added and both aliquots were incubated overnight at 37
 
8
 
C.
For SDS-PAGE analysis of precipitates, reducing or non-reducing
Laemmli sample buffer was added and the samples were either
boiled for 5 min or incubated at room temperature for 30 min
before analysis by SDS-PAGE (10.5–12%). Gels were treated for
fluorography with 125 mM salicylate, dried and exposed to film.
Bands were quantitated with a Bio-Rad GS-525 Molecular Im-
ager, subtracting the background obtained by integrating a blank
area of the appropriate size on each gel.
 
Affinity Purification of Radiolabeled Class II Complexes and HLA-
DM.
 
Affinity purification of 
 
ab
 
I, 
 
ab
 
LIP, 
 
ab
 
CLIP, and 
 
ab
 
peptide complexes from radiolabeled cell lysates were as previ-
ously described (14, 29, 43). The affinity purification of HLA-
DM from wild-type B-LCLs has also been described (29).
 
SDS Stability Assay.
 
Affinity-purified HLA-DM (2 ng) was
incubated with 500 nM MOMP peptide and 
 
z
 
10,000 CPM of
radiolabeled mutant (10.24.6-derived) or wild-type 
 
ab
 
CLIP
complexes in TBS (pH 8), 1% CHAPS. The pH was adjusted to
5.0 by the addition of 1 M acetic acid and the samples were incu-
bated at 37
 
8
 
C for 0–120 min. After neutralization by the addition
of 1 M Tris, 10
 
3
 
 non-reducing Laemmli sample buffer was
added and the samples were separated by 10.5% SDS-PAGE.
 
In Vitro Association Assay.
 
Affinity–purified, radiolabeled 
 
ab
 
I,
 
ab
 
LIP/SLIP, 
 
ab
 
CLIP, 
 
ab
 
 peptide, or 10.24.6 
 
ab
 
CLIP com-
plexes (
 
z
 
40,000 CPM) in TBS (pH 8), 1% CHAPS were incu-
bated in the absence or presence of either 50 ng affinity-purified
DM or decreasing amounts of DM (50 ng to 0.156 ng) and the
pH was adjusted to 5.0 by the addition of 1 M acetic acid. After 
2155
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an incubation at 37
 
8
 
C for 20–30 min, the samples were placed on
ice and 500 
 
m
 
l of 50 mM sodium acetate, 150 mM NaCl (pH 6.0),
1% CHAPS and 2 
 
m
 
l anti-DM or anti-C23V and 25 
 
m
 
l protein
A–Sepharose were added. The samples were incubated for 30
min at 4
 
8
 
C with rotating, washed three times with 50 mM so-
dium acetate, 150 mM NaCl (pH 6.0), 1% CHAPS, analyzed by
SDS-PAGE and quantitated by image analysis.
 
In Vitro Stabilization Assay.
 
Radiolabeled DR3 
 
ab
 
CLIP com-
plexes (10,000 cpm; 25 nM) were incubated in the presence or
absence of affinity-purified HLA-DM (25 nM) in TBS (pH 8.0),
1% octyl glucoside. The pH was adjusted to pH 4.5 and the sam-
ples were incubated at 37˚C for 0 to 10 h. At various time points,
MOMP peptide was added to a concentration of 1 
 
m
 
M and the
samples were incubated for an additional 45 min at 37˚C. After
neutralization by the addition of 1 M Tris, 10
 
3
 
 non-reducing
Laemmli sample buffer was added and the samples were separated
by 10.5% SDS-PAGE and analyzed by image analysis.
 
Results
 
HLA-DM and -DR Associate In Vivo.
 
HLA-DM has been
shown to mediate the exchange of CLIP for antigenic pep-
tides under acidic conditions in vitro (29–31). For DM to
catalyze the release of CLIP, it seemed likely that a direct
physical interaction between DM and class II molecules
must occur. HLA-DM is a resident of the MIIC (44–47),
and class II molecules traffic through this compartment to
be loaded with antigenic peptides by DM before subse-
quent arrival at the cell surface. Therefore, any interaction
Figure 1. (A) Kinetics of HLA-
DM and HLA-DR association in
wild-type Pala cells. Cells were
pulse labeled with [35S]methion-
ine for 15 min and chased in the
presence of an excess of me-
thionine and cysteine for the in-
dicated periods of time (h). Class
II and DM molecules were im-
munoprecipitated at each time
point from CHAPS or Triton
X-100 solubilized lysates (as in-
dicated above each gel) with the
DR-specific mAb L243 or with
a polyclonal rabbit antiserum
specific for the DM heterodimer
(aDM) and analyzed by SDS-
PAGE (10.5%). Control precip-
itates were performed from
CHAPS solubilized lysates with
an antiserum specific for an in-
fluenza hemagglutinin peptide
(aC23V). The bands corre-
sponding to the DMa, DMb,
DRa and DRb proteins are
marked on the right and an I
degradation fragment is indicated
by a solid arrow head. (B) HLA-
DM does not associate with
HLA-DR in 10.24.6 cells ex-
pressing a mutant DRa chain
containing an extra N-linked
glycan. Mutant 10.24.6 and
wild-type 8.1.6 cells were pulsed
labeled, chased and immunopre-
cipitated as in A. The positions
of the individual class II and
DMa and b chains are indicated
on the right and a9 marks the
position of the mutant DRa
chain expressed by 10.24.6 cells.2156 Interaction with HLA-DM Stabilizes Empty HLA-DR Molecules
between DM and DR molecules should occur in the MIIC
and be transient in nature. Sanderson et. al. (32), have
demonstrated direct DM-DR association under steady-state
conditions in vivo. To examine the kinetics of DM-DR asso-
ciation, wild-type Pala cells were pulsed for 15 min with
[35S]methionine and chased in the presence of 15-fold ex-
cess methionine and cysteine for up to 12 h (Fig. 1 A). At
each time point, radiolabeled cells were lysed in 1% CHAPS
and split into four aliquots. One aliquot was immunopre-
cipitated with a polyclonal rabbit antiserum to the DM het-
erodimer (anti-DM) and another with a negative control
rabbit antiserum to an influenza hemagglutinin peptide
(anti-C23V). DM and DR have similar mobilities on SDS-
PAGE, however their processing patterns are somewhat
different. DM-DR association has been shown to be sensi-
tive to the detergent used for solubilization of the cells (32;
unpublished data). To determine the exact position and
processing pattern of DM and DR on SDS-PAGE, 1% Tri-
ton X-100 was added to the other two aliquots of cell
lysate to dissociate the DM-DR complexes. Immunopre-
cipitation was performed with anti-DM or with the DR-
specific mAb, L243, followed by extensive washing with a
buffer containing Triton X-100 and SDS (see Materials and
Methods) to ensure any remaining DM-DR complexes
were dissociated. SDS-PAGE analysis (Fig. 1 A, lower right)
shows that in Pala cells L243-reactive ab dimers were ini-
tially generated between 1 and 2 h of chase and that proba-
ble invariant chain fragments (26; indicated on the right
hand side with an arrow) were coprecipitated with the DR
molecules early in the chase period (1 to 4 h). Immunopre-
cipitation with anti-DM serum (Fig. 1 A; upper right) re-
vealed the position of the DMa and DMb chains in the
absence of any associated DR molecules. DM ab dimers
were observed immediately after the pulse and remained
throughout the chase period, consistent with previous re-
ports (42). Comparison of the anti-DM and L243 immu-
noprecipitates in Triton X-100 clearly demonstrates that
the DM and DR processing patterns on SDS-PAGE are
very different. SDS-PAGE analysis of an anti-DM immu-
noprecipitate in the detergent CHAPS (Fig. 1A; upper left)
showed that after the pulse point, only the DM ab dimer
was precipitated. However, after 1 h of chase additional
species with the same mobilities as DRa and b subunits
coprecipitated with the DM dimers. The coprecipitated
species peaked at 2 h and then decreased with time, with
some remaining associated even at the 12 h time point. Ad-
ditionally, fragments of the invariant chain (marked with an
arrow) were coprecipitated with the DM complex at 2 h
indicating that DM can associate with putative DR mole-
cules still complexed with these fragments, suggesting that
HLA-DM is associated with the class II-I chain complex
during degradation of the I chain.
DM-positive 10.24.6 cells express a mutant DR a chain
containing a proline to serine substitution at position 96
that results in the addition of an extra N-linked glycan. In
this cell line DR3 ab dimers accumulate as abCLIP com-
plexes (35). Purified abCLIP complexes from 10.24.6 can-
not be loaded with peptide by recombinant soluble DM in
vitro (31) or by affinity-purified native DM (see below),
and steady-state DM-DR association is greatly reduced in
this cell line (32). To confirm that the putative DR-DM
interaction seen in wild-type Pala cells was specific, we re-
peated the pulse-chase experiment with the 10.24.6 cell
line and the matched parental cell line, 8.1.6 (35). The re-
sults (Fig. 1 B, upper left) showed that in the wild-type cell
line 8.1.6, DR was coprecipitated with DM and that this
association was strongest at 1–2 h of chase, similar to what
was observed in Pala cells (Fig. 1 A). In 10.24.6 cells, anti-
DM and L243 (anti-DR) precipitations in Triton X-100
clearly showed that this cell line expresses both DM and
Figure 2. (A and B) HLA-DM associates with DR in a post-Golgi
compartment. Pala cells were pulsed labeled with [35S]methionine for 15
min and chased for the indicated periods of time (h). DM-DR complexes
were immunoprecipitated at each time point from CHAPS solubilized
lysates with anti-DM (aDM). DM-associated class II molecules were
eluted with 0.5% DOC and the supernatants reprecipitated with DR b
chain-specific mAb HB10A (A) or control mAb W6/32 (B). The precip-
itates were either treated with Endo H or mock treated and analyzed by
SDS-PAGE (10.5%). Locations of Endo H resistant (R) and sensitive (S)
DR a and b bands are indicated on the right. (C) HLA-DM associates
with SDS-stable ab dimers. Pala cells were pulse labeled, immunoprecip-
itated and re-precipitated with mAb HB10A as in A. After the addition of
Laemmli sample buffer, the precipitates were incubated at room tempera-
ture for 30 min and analyzed by SDS-PAGE (10.5%). The positions of the
individual a and b chains and the ab dimers are indicated on the right.2157 Denzin et al.
DR (Fig. 1 B lower right). The reduced mobility of the mu-
tant DRa chain (a9) caused by the additional N-linked
glycan is readily apparent. None of the mutant DR was co-
precipitated with DM in CHAPS (Fig. 1 B, upper right)
even upon prolonged autoradiographic exposure (data not
shown).
DM Associates with DR in a Post-Golgi Compartment.  Pulse-
chase analysis (Fig. 1 A) showed that DM-DR association
was maximal after 1–2 h of chase, the time at which the
abI complex is delivered into the MIIC and the invariant
chain is being degraded in this cell line (46; unpublished re-
sults). Therefore, the interaction must occur in a post-Golgi
compartment and the DM-associated DR should be resistant
to Endo H digestion. To determine this, wild-type Pala
cells were pulse-labeled for 15 min with [35S]methionine
and chased in the presence of an excess of methionine and
cysteine. After lysis of the cells in CHAPS, the DM–class II
complexes were immunoprecipitated with anti-DM. The
coprecipitated DR was eluted from the DM immunopre-
cipitates with 0.5% DOC and reprecipitated from superna-
tants with a DR b chain–specific mAb, HB10A or with a
negative control antibody to HLA class I molecules, W6/
32. Duplicate HB10A and W6/32 precipitates were treated
with Endo H or mock-treated overnight and analyzed by
SDS-PAGE. No DM associated DR was detected early in
transport since the faint Endo H–sensitive bands present
immediately after the pulse in the HB10A precipitates (Fig.
2 A) were also present in the negative control precipitates
(Fig. 2 B). As observed in Fig. 1, DM-associated DR was
first detected after 1 h of chase and the associated DR was
resistant to Endo H digestion (Fig. 2 A, note that one of
the DRa chain N-linked glycans remained in the high
mannose form upon maturation; 48). These data indicate
that DM and DR are not associated in the ER and that
DM-DR must interact after the DR molecules have tra-
versed the medial Golgi. No HLA class I molecules were
coprecipitated with DM, verifying the specificity of the
DR-DM association (Fig. 2 B).
DM can be coprecipitated by the DR3 conformational
specific mAb 16.23 (32). This antibody is thought to rec-
ognize only peptide loaded DR3 molecules and does not
bind abI or abCLIP complexes (49). Sanderson et al. (32),
suggest that because DM can be efficiently coprecipitated
by mAb 16.23, that the DM is able to associate with ma-
ture, peptide-loaded DR3 molecules. Since the exact spec-
ificity of mAb 16.23 is not known, the DM associated DR
they observed may actually be empty DR3 molecules.
SDS-stability of class II molecules has been shown to corre-
late with peptide binding (50). To determine if DM can as-
sociate with peptide-loaded DR molecules, Pala cells were
pulsed with [35S]methionine, chased for various times, ex-
tracted in CHAPS, and immunoprecipitated with anti-
DM. After release of the DM-associated DR by 0.5%
DOC, the DR was reprecipitated with HB10A as de-
scribed above. The HB10A immunoprecipitates were in-
cubated in SDS-PAGE sample buffer at room temperature
for 30 min and analyzed by SDS-PAGE for SDS-stable,
peptide-loaded ab dimers. The peak of class II association
with DM was again at 2 h, and at this time the majority is
clearly unstable. However, stable ab dimers were clearly
present, indicating that DM can associate with mature,
peptide-loaded ab dimers (Fig. 2 C). This result is repro-
ducible and does not reflect an artefactual, post-solubiliza-
tion association of DM and mature DR molecules, because
coextraction under the same conditions of labeled T2.DR3
cells mixed with unlabeled T2.DM cells did not generate
such complexes (data not shown). Although the relative
amount of the total DR that was SDS-stable increased with
time, the majority of the DM-associated DR was not stable
in SDS. This suggests that most of the peptide loaded DR
dissociated from DM during the chase.
DM Associates with abLIP and abSLIP Complexes In
Vivo. We have shown that DM is able to catalyze in vitro
the removal of LIP, a 21-kD NH2-terminal fragment of the
Figure 3. HLA-DM associates with abLIP and abSLIP complexes. (A)
Pala cells were pulse labeled for 15 min with [35S]methionine and chased
for 2 h in the presence of an excess of methionine and cysteine. Class II,
DM and I chain molecules were immunoprecipitated from CHAPS solu-
bilized lysates with anti-DM (aDM) or control anti-C23V (aC23V) or
from Triton X-100 solubilized lysates with anti-DM, DR-specific mAb
L243, I chain–specific mAb PIN.1 or control mAb GAP.A3 and analyzed
by SDS-PAGE (12%). (B) Wild-type Pala cells were pulse labeled and
chased as in A. DM-associated class II and class II–I chain complexes were
eluted with 0.5% DOC, the supernatants reprecipitated with mAbs
PIN.1, HB10A, and W6/32 (control) and analyzed by SDS-PAGE (12%).
The positions of the individual DR a and b chains and LIP are indicated
on the right. The right lane shows the HB10A-precipitated material run
without boiling the sample.2158 Interaction with HLA-DM Stabilizes Empty HLA-DR Molecules
I chain that accumulates in the presence of the protease in-
hibitor leupeptin, from abLIP complexes (29). This sug-
gested that DM can interact with class II complexed with
fragments of the I chain. Additionally, pulse–chase analysis
of DM in the detergent CHAPS (Fig. 1 A) demonstrated a
band at 2 h that coprecipitated with DM and probably is a
fragment of the I chain. To directly examine if DM can in-
teract with DR complexed with I chain fragments, Pala cells
were pulsed with [35S]methionine for 15 min and chased
for 2 h in the presence of the protease inhibitor leupeptin
to accumulate abLIP (14) and abSLIP (15) complexes.
Radiolabeled cells were lysed in CHAPS, immunopre-
cipitated with anti-DM or anti-C23V (negative control), or
lysed in CHAPS plus Triton X-100 and immunoprecipi-
tated with anti-DM, the DR specific mAb L243, the I chain
specific mAb PIN.1, or the HLA-A3 specific mAb, GAP.A3
(negative control) and analyzed by SDS-PAGE. Immedi-
ately after the pulse, as expected, no DM-associated DR
was observed and no abLIP and abSLIP had yet been
generated (Fig. 3 A). After a 2-h chase, the mAb L243 pre-
cipitated DR ab in addition to lower molecular weight
fragments of the I chain, LIP and SLIP (which runs on the
dye front of the gel). Immunoprecipitation with anti-DM
showed that abLIP and abSLIP complexes were coprecip-
itated with DM in the detergent CHAPS but not in Triton
X-100 (Fig. 3 A), as observed in Fig. 1. These results show
that DM can associate with DR complexed with I chain
fragments.
Previous in vivo analysis has shown that DM coprecipi-
tated with full-length I chain in the ER and with I chain
fragments (including LIP) in dense Percoll gradient frac-
tions (32). However, these experiments were performed
using immunoprecipitation with an antibody specific for
the NH2-terminal region of the I chain (VICY1) followed
by Western blotting, and thus it was impossible to distin-
guish between direct DM interaction with the I chain or
association with the I chain via its interaction with class II
molecules. A similar problem exists in the experiment
Figure 4. (A and B) HLA-
DR3 abCLIP complexes from
10.24.6 cells cannot be loaded by
affinity-purified HLA-DM in
vitro. Purified HLA-DR3 ab-
CLIP complexes from T2.DR3
and mutant 10.24.6 cells were
incubated with the DR3-restricted
MOMP peptide and 2 ng of af-
finity-purified HLA-DM at 378C
for the indicated times at pH 5.0.
After neutralization, samples were
analyzed by SDS-PAGE (10.5%)
(A) and the percent SDS-stable
dimers formed at each time point
quantitated by image analysis
(B). The positions of the indi-
vidual a and b chains and ab
dimers are indicated on the right.
(C and D) HLA-DM associates
with abCLIP complexes in vitro.
Radiolabeled abCLIP complexes
from T2.DR3 and 10.24.6 cells
were incubated in the presence
(50 ng) or absence of affinity-
purified HLA-DM at 378C for
30 min at pH 5.0. The pH was
adjusted to 6.0 and the reaction
mixtures were immunoprecipi-
tated with anti-DM (aDM) or
control anti-C23V (con.) and an-
alyzed by SDS-PAGE (10.5%)
(C) and quantitated by image
analysis (D). The lanes labeled
Total abCLIP represent one-
tenth the amount of radiolabeled
abCLIP used in the reaction
mixture and was used to calcu-
late the percentage DM associ-
ated class II (% Associated). IP in
C, indicates the antibody used
for immunoprecipitation.2159 Denzin et al.
shown in Fig. 3 A. An experiment was designed to deter-
mine whether the DM-associated I chain fragments seen in
Fig. 3 A were free or complexed to class II molecules. Pala
cells were pulsed for 15 min with [35S]methionine, chased
for 2 h in the presence of leupeptin, lysed in CHAPS and
immunoprecipitated with anti-DM. The DM-associated
material was eluted by the addition of 0.5% DOC, which
should not dissociate abI or ab complexed to fragments of
the I chain. The eluted complexes were reprecipitated
from the DOC supernatant with mAb PIN.1 (anti-I chain),
mAb HB10A (anti-DR b chain) or a negative control mAb
W6/32 (anti-class I). SDS-PAGE analysis of the immuno-
precipitates is shown in Fig. 3 B. Immunoprecipitation
with the class II specific mAb HB10A showed that after a
15-min pulse, no class II was associated with DM and re-
precipitation with an antibody specific for the I chain
showed that very little, if any, I chain was associated with
DM. After 2 h of chase, re-precipitation of DM-associated
class II with mAb HB10A showed that LIP was clearly
present, demonstrating that DM interacts with abLIP
complexes. Reprecipitation with the I chain specific mAb
PIN.1 also precipitated abLIP complexes. Because HLA-
DM can bind to abCLIP and ab peptide complexes (see
below), it seems likely that DM associates with LIP via an
interaction with the DR molecule and not directly with
the LIP fragment itself.
Mutant abCLIP Complexes Cannot Be Loaded by Affinity-
purified HLA-DM. Class II molecules containing a mutant
DR a chain in the DM positive 10.24.6 cell line are unable
to associate with DM and therefore arrive at the cell surface
complexed with CLIP (Fig. 1 B; 32, 35). To determine if
10.24.6-derived abCLIP complexes could be loaded in
vitro by native DM we compared the rates at which mu-
tant and wild-type abCLIP complexes could be converted
to SDS-stable dimers. T2.DR3 and 10.24.6 cells were
pulsed with [35S]methionine for 4 h and chased in the pres-
ence of a 15-fold excess of methionine and cysteine for 16 h
to ensure degradation of the I chain and maturation of the
abCLIP complexes. Mutant and wild-type abCLIP com-
plexes were affinity-purified from radiolabeled cell lysates
using a CerCLIP.1 antibody column. Radiolabeled wild-
type and mutant DR3 abCLIP complexes and the DR3-
specific peptide MOMP were added to affinity-purified
DM and incubated at pH 5 for periods up to 120 min at
378C (29). After neutralization, the samples were analyzed
by SDS-PAGE. The kinetics of DM-induced dimer forma-
tion for wild-type abCLIP complexes showed that SDS-
stable ab dimers were detected after only 5 min of incuba-
tion at 378C and the formation of dimers proceeded rapidly
for the first 30–45 min of incubation before leveling off
(Fig. 4, A and B). In contrast, abCLIP complexes purified
from 10.24.6 molecules were inefficiently loaded by affin-
ity-purified DM. After 120 min only 18% of the mutant
abCLIP complexes were converted to SDS-stable dimers
compared to 95% dimers for wild-type abCLIP. These re-
sults show that native DM is unable to efficiently load mu-
tant abCLIP complexes from 10.24.6 cells and confirm the
results of Sloan et al. (31), who demonstrated that the mu-
tant abCLIP complexes cannot be loaded in vitro by re-
combinant, soluble DM.
DM Associates with abCLIP Complexes In Vitro. DM is
able to catalyze the removal of CLIP from abCLIP com-
plexes and exchange it for antigenic peptides in vitro (29–31).
This suggests that DM and DR must associate during the in
vitro reaction. To look for such an interaction, radiola-
beled, CerCLIP.1-purified normal abCLIP from T2.DR3
or mutant abCLIP from 10.24.6 were added to affinity-
purified DM and incubated at pH 5.0 for 20–30 min at
378C. After adjusting the pH to 6.0, the reaction mixtures
were immunoprecipitated with anti-DM or anti-C23V,
which served as a negative control antibody, and analyzed
by SDS-PAGE. When affinity-purified DM and wild-type
DR abCLIP complexes were incubated together, anti-
DM but not anti-C23V coprecipitated the radiolabeled
DR (Fig. 4 C). However, DM failed to form a detectable
complex with mutant abCLIP, since immunoprecipitation
with anti-DM did not coprecipitate radiolabeled mutant
DR. Image analysis (Fig. 4 D) indicated that 14% of the a
and b chains from wild-type abCLIP was coprecipitated
with DM, whereas less than 4% of those of the mutant ab-
CLIP complexes were coprecipitated (Fig 4 D). These
results show that DM and DR abCLIP complexes do in-
teract in vitro and that no additional components are nec-
essary for the interaction. CLIP, which runs below the dye
front on SDS-PAGE (29), is conspicuously absent from the
class II complex coprecipitated by anti-DM in Fig. 4 C,
even though it can readily be seen in the initial abCLIP
complex (second lane from the right). DM appears to be
associated with empty class II ab dimers in this experi-
ment, because no peptides were added to the reaction mix-
ture. CLIP is consistently absent from or severely reduced
in complexes formed by incubating DM with abCLIP.
DM Stabilizes Empty Class II Molecules. Empty class II ab
dimers have been shown to aggregate and lose their ability
to bind antigenic peptides (51–53). The absence of CLIP
from class II complexes coprecipitated with DM (Fig. 4 C)
indicated that DM continues to interact with empty class II
molecules after CLIP dissociation. Such an association
might stabilize the ab dimers and prevent them from ag-
gregating and losing the capacity to bind antigenic pep-
tides. To test this hypothesis, we took advantage of the
ability of the detergent octyl glucoside to induce CLIP re-
lease from DR3 abCLIP complexes (21, 27). Radiolabeled
DR3 abCLIP complexes were incubated in 1% octyl glu-
coside at pH 4.5 with the DR3-specific MOMP peptide in
the presence and absence of affinity-purified DM. After
acidification and incubation for 0 to 10 hr at 378C, the
samples were neutralized, analyzed by SDS-PAGE and
quantitated by image analysis. The results showed that the
conversion of class II abCLIP complexes to ab peptide
complexes in the detergent octyl glucoside was almost as
efficient in the absence of DM as in its presence. By 6 h,
the percentage of SDS-stable dimers was virtually identical
(z90%; Fig. 5, A and B). This demonstrates that octyl glu-2160 Interaction with HLA-DM Stabilizes Empty HLA-DR Molecules
coside can induce CLIP release from class II abCLIP com-
plexes almost as efficiently as DM under these experimental
conditions. To determine whether DM could stabilize
empty class II molecules, radiolabeled abCLIP complexes
were incubated without peptide in 1% octyl glucoside in
the presence and absence of DM at pH 4.5 for 0–10 h. At
each time point, MOMP peptide was added to 1 mM and
the samples were incubated for an additional 45 min at
378C to allow surviving, functional class II molecules to
bind peptide. After neutralization, the samples were ana-
lyzed by SDS-PAGE and quantitated by image analysis.
The results showed that after only 1 h of incubation in the
absence of peptide more peptide-receptive class II mole-
cules survived in the presence of DM (Fig. 5 C). With in-
creasing incubation time, the amount of peptide-receptive
class II progressively decreased both with and without DM.
However, at all time points the presence of HLA-DM re-
sulted in increased peptide loading. After 10 h of incuba-
tion no peptide-receptive class II molecules were present in
the absence of DM, whereas z35% of class II molecules re-
tained their peptide binding function when DM was
present (Fig. 5, C and D). Control proteins at the same or
10-fold higher concentrations failed to preserve peptide-
receptive class II molecules demonstrating that this function
is a specific property of HLA-DM (data not shown).
DM Interacts In Vitro with ab Dimers Associated with I
Chain Fragments or Endogenous Peptides but not abI Com-
plexes. During transport, maturing class II complexes have
many opportunities to interact with DM. In vivo pulse-
chase (Figs. 1–3) and steady-state Western blotting experi-
ments (32) showed that DM does not coprecipitate with
abI complexes, but can be coprecipitated with ab com-
plexed to I chain fragments (LIP) and with peptide-loaded
ab dimers. Lack of association with abI, particularly,
could either be a reflection of limiting amounts of DM in
the ER and later abI-containing compartments or of an
inability of DM to interact. To examine this question,
[35S]methionine-labeled abI, abLIP/SLIP and mature ab
dimers were purified from wild type cells. SDS-PAGE of
the purified abI, abLIP/SLIP, abCLIP, and ab peptide
complexes used for the in vitro association assays are shown
in Fig. 6 A. The loaded samples represent one-tenth the
amount of each complex used for the association assay. In
this particular experiment, the SLIP fragment (15) was un-
Figure 5. Stabilization of empty class II molecules by HLA-DM. (A and B) Loading of class II abCLIP complexes in octyl glucoside versus loading in
octyl glucoside and DM. Purified HLA-DR3 abCLIP complexes (25 nM) from T2.DR3 cells were incubated in 1% octyl glucoside with the DR3-spe-
cific MOMP peptide in the presence or absence of 25 nM affinity-purified HLA-DM at 378C for the indicated times at pH 4.5. After neutralization,
samples were analyzed by SDS-PAGE (A) and the percent SDS-stable dimers formed in the presence and absence of HLA-DM at each time point were
quantitated by image analysis (B). The positions of the individual a and b chains and the ab dimers are indicated on the right. (C and D) HLA-DM sta-
bilizes empty class II molecules. Radiolabeled DR3 abCLIP complexes (25 nM) were incubated at 378C in 1% octyl glucoside in the presence and ab-
sence of HLA-DM (25 nM) for the indicated times at pH 4.5. At each time point, 1 mM MOMP peptide was added and the samples were incubated at
378C for an additional 45 min. After neutralization, samples were analyzed by SDS-PAGE (C). To quantitate the results in panel C, the amount of SDS-
stable dimers at each time point is represented in panel D as the percentage of the maximal available SDS-stable dimers generated at the same time point
in the presence and absence of DM but with MOMP continuously present (B).2161 Denzin et al.
usually well represented in the class II molecules purified
from leupeptin-treated Pala cells. For association experi-
ments, the various complexes were incubated in the pres-
ence and absence of affinity-purified DM at pH 5.0 for 30
min at 378C, immunoprecipitated with anti-DM or anti-
C23V (negative control) and analyzed by SDS-PAGE (Fig.
6 B). The results showed that DM interacted detectably
with abLIP/SLIP, abCLIP, and ab peptide complexes,
but not with abI. In other experiments we were unable to
detect association of DM with affinity-purified I chain tri-
mers (data not shown). Image analysis of the co-association
experiment (Fig. 6 C) suggested that DM interacted better
with abCLIP complexes than with abLIP/SLIP or ab
peptide complexes. To better quantitate the interactions,
titrated amounts of purified DM were added to each of the
purified class II complexes and the percentage of each class
II complex coprecipitated with DM was determined for
each concentration. The results were quantitated by image
analysis after SDS-PAGE (Fig. 6 D). DM clearly associated
better with class II molecules when abCLIP was used than
when ab dimers complexed with larger I chain fragments
or ab peptide complexes were used. These results probably
reflect prolonged association with empty ab dimers after
CLIP dissociation (see Fig. 5). Interaction with abI was es-
sentially undetectable.
Discussion
Upon arrival in the MIIC, the I chain component of abI
complexes is degraded, leaving CLIP as a residual fragment
bound to class II ab dimers. Through a process mediated
by HLA-DM, CLIP is exchanged for endocytically gener-
ated peptides and the mature class II molecules are trans-
ported to the cell surface (29–31). This process implies a
physical interaction between class II molecules and HLA-
DM. In this paper, we have confirmed that such an interac-
tion, first described by Sanderson et al. (32), occurs in vivo,
and have complemented this finding by analyzing the spec-
ificity of the interaction for different class II complexes in
vitro. In addition, we have shown that HLA-DM associates
with empty class II molecules after CLIP dissociation, and
that this association increases the stability of the peptide-
free ab dimers, prolonging their ability to bind peptides.
Figure 6. HLA-DM interacts in vitro with ab dimers associated with I chain fragments or endogenous peptides but not abI. (A) SDS-PAGE (12%)
analysis of radiolabeled, purified abI, abLIP/SLIP, abCLIP, and ab peptide complexes used for the experiments shown in B and D. The positions of
the individual DR a and b chains are indicated on the right and the positions of the I chain (p41/43 and p33/35), LIP, SLIP and CLIP are indicated on
the left. (B and C) Radiolabeled complexes (as indicated) were incubated in the presence and absence of purified DM at 378C for 30 min at pH 5.0, the
pH was adjusted to 6.0 and the reaction mixtures were immunoprecipitated with anti-DM (aDM) or control anti-C23V (con.). After analysis of the pre-
cipitates by SDS-PAGE (12%) (B), the results were quantitated by image analysis (C) to determine the relative percentage each DR complex that re-
mained associated with DM. (D) Purified complexes were incubated with various concentrations of affinity-purified HLA-DM as indicated (50 ng to
0.156 ng) at 378C for 30 min at pH 5.0 and the reaction mixtures were immunoprecipitated with anti-DM. After analysis of the precipitates by SDS-
PAGE, the percentage of each class II complex coprecipitated with DM was determined for each concentration by image analysis.2162 Interaction with HLA-DM Stabilizes Empty HLA-DR Molecules
HLA-DM is a resident protein of MIICs (44–47). Not
surprisingly, therefore, the interaction between class II mole-
cules and HLA-DM is readily detectable at steady state in
dense Percoll fractions (32). Examination of the kinetics of
the interaction by pulse-chase analysis (Fig. 1), shows that it
is transient, peaking at the time when, based on our previ-
ous experiments, HLA-DR molecules arrive in MIICs (46;
unpublished data). Consistent with this, DM association is
not seen until the class II molecules are resistant to Endo
H digestion (Fig. 2). Additionally, in MIICs purified by a
combination of Percoll gradient separation and immu-
noisolation using an antibody to the DMb cytoplasmic do-
main, we have also been able to observe DM-DR association
after CHAPS solubilization (Hammond, C., unpublished ob-
servations).
There are two possible, non-mutually exclusive, expla-
nations for the peak of DM-DR association occurring in
MIICs. First, this is believed to be where abCLIP is gener-
ated and abCLIP could be the optimal form of class II for
DM binding. Second, the interaction could peak in MIICs
because this is the organelle where DM is maximally con-
centrated. At one extreme, all the forms of class II (abI
through ab with endocytically acquired peptides) could
bind equally well to DM, but because DM is encountered
primarily in MIICs, only the later forms would be found to
associate in vivo. Some evidence for this is seen in Fig. 1,
where what appears to be an I chain fragment is coprecipi-
tated with DM, consistent with the idea that ab dimers
with residual I chain fragments can bind. If complexes of
class II with I chain fragments are deliberately induced by
leupeptin treatment, their in vivo association with DM is
even more dramatically evident (Fig. 3; 32). Under such
conditions, these complexes accumulate in MIICs. In addi-
tion, it is clear that SDS-stable dimers, presumably loaded
with peptides other than CLIP, can associate with DM
(Fig. 2 C). At later times in the chase these may represent
an internalized subset of surface class II molecules. They do
not reflect an artefactual, post-solubilization association of
DM and mature DR molecules, because coextraction un-
der the same conditions of labeled T2.DR3 cells mixed
with unlabeled T2.DM cells did not result in the formation
of such complexes (data not shown).
To properly determine the specificity of DM for the dif-
ferent forms of maturing class II molecules, the develop-
ment of an in vitro binding assay was essential. Such an
assay also allows one to differentiate between a binding in-
teraction between class II and DM and the functional activ-
ity of DM. We previously found that abLIP and abCLIP
were substrates for DM-mediated peptide loading, whereas
abI and mature ab peptide complexes from wild-type
DR3-positive Pala cells were not (29). The experiments in
Figs. 4 and 5 show that DR3 abCLIP, abLIP/SLIP, and
ab peptide complexes can all associate with HLA-DM un-
der the in vitro conditions used, whereas abI complexes
do not. The abCLIP complexes associate best although
mutant abCLIP complexes from the 10.24.6 cell line,
which fail to bind antigenic peptides when incubated with
DM (31; Fig. 4, A and B), fail to associate with HLA-DM
both in vivo (32; Fig. 1 B) and in vitro (Fig. 4, C and D).
Thus, binding and functional susceptibility correlate well,
with the exception of mature ab peptide complexes which
bind to HLA-DM but exchange peptides poorly (29).
CLIP-containing  ab dimers from the cell line 10.24.6 pre-
sumably do not bind DM because of steric interference by
the additional N-linked glycan on the mutant a chain (35).
Similarly, abI complexes may not bind to DM because the
COOH-terminal region of the I chain, which has been
postulated to interact directly with the ab dimer (54, 55)
also sterically interferes with the interaction.
The in vitro association of DM with class II molecules is
relatively inefficient. In the experiments shown in Figs. 4
and 6, DM was added in a large excess over DR and in the
best experiments only z15% of the class II (in this case,
abCLIP) added is recoverable as DM-associated material.
This inefficiency is probably attributable to several limita-
tions of the in vitro system. First, it has been shown that
DM-DR complexes are more efficiently isolated from in-
tact cells at pH 5.0 than at pH 7.0 (32). The use of immu-
noprecipitation to recover DM-DR complexes required
increasing the pH from 5.0 to 6.0, a pH at which the DM-DR
complex may not be particularly stable. Second, DM and
DR molecules are present in vivo in a membrane-bound
form and are concentrated in MIICs. These conditions are
not met in vitro. Additionally, there could be other pro-
teins that stabilize the DM-DR interaction in vivo which
are absent from our assay. However, we think this is un-
likely since purified, soluble recombinant DM appears to
be fully functional in vitro. DM-DR association in vitro
may be inefficient simply because the complex is in equi-
librium with free class II and DM, so that any time only a
fraction of the DM and DR are associated.
The substoichiometric levels of DM compared to class II
in vivo (29, 42) suggest that DM acts catalytically on multi-
ple class II molecules. One way to ensure that DM interacts
with many class II molecules would be to regulate DM-
class II association by equilibrium. It has been demonstrated
that in clones of wild-type human Swei cells transfected
with I-Ab, low DM expression results in more abCLIP and
less ab peptide being expressed at the cell surface (56). Ra-
machandra et al. (56), use this data to argue that there must
be a quasi-stoichiometric ratio of class II to DM for efficient
peptide loading, and that DM may not be functioning cata-
lytically. However, if class II moves through the MIIC at
the same rate, less DM could still result in less peptide load-
ing of abCLIP complexes.
Previously, we reported that DM does not associate with
I chain in the detergent Triton X-100 (42), and in vitro as-
sociation experiments in which affinity-purified I chain tri-
mers were incubated with affinity-purified DM in the de-
tergent CHAPS also failed to demonstrate an interaction
(data not shown). However, Karlsson and co-workers have
provided good evidence in the mouse system that DM and
the I chain can associate in vivo (57). Removal of the cyto-
plasmic tail of the mouse DM b chain and coexpression2163 Denzin et al.
with the a chain resulted in cell surface expression of
mouse DM (57, 58). When the transfected molecule was
coexpressed with I chain, it was redistributed to MIIC,
showing that the two proteins interact (57). Additionally,
association between DM and I chain has been detected by
coprecipitation experiments in the detergent digitonin (32,
47, 57). However, Sanderson et al. (32), demonstrated that
the DM-associated I chain complex never became Endo
H–resistant, indicating that the complex failed to leave the
ER, a result which we have confirmed (data not shown).
Such a complex may result from mis-assembly in the ER.
Pulse–chase analysis of DM in CHAPS (Fig. 1 A) showed
that fragments of the I chain are coprecipitated with DM.
However, elution of the DM associated proteins followed
by reprecipitation indicated that the majority, and perhaps
all, of the I chain fragments are still complexed to class II
molecules (Fig 3; unpublished results). Overall, the data ar-
gue against a functionally important direct interaction be-
tween DM and the I chain, at least in the human system.
What is the physiological substrate for DM in wild-type
cells? Recent in vitro experiments have implicated ab-
CLIP as the DM substrate although some other peptides
can also be removed from ab dimers by DM (31), and
abLIP can serve as an in vitro substrate (29). The data pre-
sented here are consistent with the hypothesis that abCLIP
is the preferred substrate. First, the level of class II associa-
tion with DM in vitro is much higher when abCLIP com-
plexes, rather than abLIP/SLIP or ab peptide complexes,
are used (Fig. 6). Second, when abCLIP is incubated with
DM, virtually no CLIP is visible in the DM-class II com-
plex formed (e.g., Fig. 4 C). This is also true for DM-DR
complexes isolated from intact cells. For example, in Fig. 1 A,
upper left, no CLIP is visible below the dye front where it
normally runs, even at the peak of DM-DR association and
even upon over-exposure of the gels (data not shown). A
reasonable hypothesis to explain this is that CLIP release is
so readily mediated by DM that it does not remain associ-
ated for any significant period after the complex forms.
Thus, the higher level of a and b subunit association with
DM seen when abCLIP is added, compared to when
abLIP/SLIP or ab peptide is added, could be because DM
actually has a higher affinity for empty class II molecules
than for class II molecules occupied with I chain fragments
or peptides.
Preferred association of HLA-DM with empty class II
molecules could in part account for its ability to catalyze
peptide loading. HLA-DM molecules may bind with ab
dimers associated with CLIP, other peptides or I chain
fragments. This interaction might favor a conformation (or
stabilize a transition state; 28) which has a significantly re-
duced affinity for CLIP and certain other peptides, but not
for the majority of bound peptides. After dissociation of
CLIP, stabilization of the empty molecules by DM associa-
tion (Fig. 5) could enhance their ability to associate with
other, endocytically generated, peptides. The COOH-ter-
minal region of the I chain has been reported to stabilize
empty recombinant DR1 molecules, which normally tend
to aggregate (51), thus enhancing in vitro peptide binding
(54). We previously observed that DM was superior to oc-
tyl glucoside in facilitating peptide binding to DR3 ab-
CLIP complexes, even though octyl glucoside was better at
inducing CLIP dissociation (29), a result now explained by
the stabilization of empty ab dimers by DM association
(Fig. 5). This chaperone-like function of HLA-DM could
also explain the finding that it can enhance antigen process-
ing involving class II alleles with a low affinity for CLIP,
for example, I-Ak (34). After spontaneous release of CLIP
from I-Ak molecules in vivo, empty I-Ak molecules may be
better preserved in MIICs by interaction with DM, en-
hancing their ability to generate functional I-Ak-peptide
complexes. Ultimately, these ideas can best be tested by
isolating and characterizing DM–DR complexes. Such ex-
periments are the next challenge in understanding the cata-
lytic function of HLA-DM.
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